Tianshu Liu

36PUBLICATIONS
118CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.

|Jun 10, 2026
Targeting ATF3-mediated asparagine biosynthesis reverses acquired resistance to KRASG12C inhibitors.

|Jun 01, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.

|Mar 19, 2026
A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study.

Wang Xicheng, Deng Yanhong, Zhang Yanqiao

|Mar 07, 2025
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial.

Kohei Shitara, Yelena Y Janjigian, Jaffer Ajani

|Nov 23, 2024
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.

Heinz-Josef Lenz, Tianshu Liu, Emerson Y Chen

Pageof 6

Frequent Collaborators

3 joint publications

Chen Xu

3 joint publications

Kuntang Shen

3 joint publications

Li Liang

3 joint publications

Yiyi Yu